$8.44
1.2817.88%
At close: -
$7.42
-1.02-12.09%
After Hours: Feb 21, 8:02 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Avalo Therapeutics in recent months.
Browse guidance and forecast on all stocks.